Safety and efficacy of reduced dosage ketoprofen with or without tramadol for long-term treatment of osteoarthritis in dogs: a randomized clinical trial
Tóm tắt
This study aimed to evaluate the safety and efficacy of reduced-dosage ketoprofen with or without tramadol in dogs. Five healthy dogs receiving standard-dosage ketoprofen (2 mg/kg SC, then 1 mg/kg PO daily) comprised Group A. Twenty dogs with osteoarthritis were randomized to receive reduced-dosage ketoprofen (0.5 mg/kg SC once; 0.25 mg/kg PO daily) alone (Group B) or in combination with tramadol (5 mg/kg/day PO) (Group C). Treatments were administered for 28 days. Platelet aggregation time (PAT), gastrointestinal (GI) endoscopy and glomerular filtration rate (GFR) were performed up to 60 days after treatment initiation. Pain was scored using a validated clinical metrology instrument up to D120. Data were analyzed with general linear mixed model for repeated measures (α = 0.05). PAT was not different between groups but was increased with time for all groups. GI lesion scores were higher in Group A than Groups B and C (day 28; P = 0.005) and were increased with time for Group A (P = 0.005). GFR was lower in Group A than Groups B and C (day 28; P < 0.01) and were decreased with time for group A (P < 0.001). Standard-dosage ketoprofen administration resulted in clinically relevant adverse effects. Pain score decreased in both treated groups (B and C) from D0 to D28. Need of rescue analgesia from D29 to D120 was higher in Group B than in Group C (P = 0.039). The long-term safety profile of reduced-dosage ketoprofen is similar whether the drug is administered alone or in combination with tramadol to dogs with osteoarthritis. Analgesic efficacy of the combination looks attractive.
Tài liệu tham khảo
Schaible H-G, Richter F, Ebersberger A, Boettger MK, Vanegas H, Natura G, et al. Joint pain. Exp Brain Res. 2009;196(1):153–62.
Mobasheri A, Batt M. An update on the pathophysiology of osteoarthritis. Ann Phys Rehabil Med. 2016;59:333–9.
Kellgren J, Samuel E. The sensitivity and innervation of the articular capsule. J Bone Jt Surg. 1950;4:193–205.
Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain Elsevier Ltd. 2009;10(9):895–926.
Aragon CL, Hofmeister EH, Budsberg SC. Systematic review of clinical trials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc. 2007;230(4):514–21.
Vandeweerd J, Coisnon C, Clegg P, Cambier C, Pierson A, Hontoir F, et al. Systematic review of efficacy of nutraceuticals to alleviate clinical signs of osteoarthritis. J Vet Intern Med. 2012;26(3):448–56.
Monteiro-Steagall BP, Steagall PVM, Lascelles BDX. Systematic review of nonsteroidal anti-inflammatory drug-induced adverse effects in dogs. J Vet Intern Med. 2013;27(5):1011–9.
Forsyth SF, Guilford WG, Pfeiffer DU. Effect of NSAID administration on creatinine clearance in healthy dogs undergoing anaesthesia and surgery. J Small Anim Pract. 2000;41(12):547–50.
Lemke KA, Runyon CL, Horney BS. Effects of preoperative administration of ketoprofen on whole blood platelet aggregation, buccal mucosal bleeding time, and hematologic indices in dogs undergoing elective ovariohysterectomy. J Am Vet Med Assoc. 2002;220(12):1818–22.
Luna SPL, Basílio AC, Steagall PVM, Machado LP, Moutinho FQ, Takahira RK, et al. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. Am J Vet Res. 2007;68(3):258–64.
Hazewinkel HAW, van den Brom WE, Theijse LFH, Pollmeier M, Hanson PD. Reduced dosage of ketoprofen for the short-term and long-term treatment of joint pain in dogs. Vet Rec. 2003;152(1):11–4.
Narita T, Tomizawa N, Sato R, Goryo M, Hara S. Effects of long-term oral administration of ketoprofen in clinically healthy beagle dogs. J Vet Med Sci. 2005;67(9):847–53.
Matthews M. The role of dose reduction with NSAID use. Am J Manag Care. 2013;19(14):s273–7.
Wernham BGJ, Trumpatori B, Hash J, Lipsett J, Davidson G, Wackerow P, et al. Dose reduction of meloxicam in dogs with osteoarthritis-associated pain and impaired mobility. J Vet Intern Med. 2011;25(6):1298–305.
Guillot M, Moreau M, Heit M, Martel-Pelletier J, Pelletier JP, Troncy E. Characterization of osteoarthritis in cats and meloxicam efficacy using objective chronic pain evaluation tools. Vet J. 2013;196(3):360–7.
Minami K, Ogata J, Uezono Y. What is the main mechanism of tramadol? Naunyn Schmiedeberg's Arch Pharmacol. 2015;388(10):999–1007.
Schaefert R, Welsch P, Klose P, Sommer C, Petzke F, Häuser W. Opioids in chronic osteoarthritis pain. A systematic review and meta-analysis of efficacy, tolerability and safety in randomized placebo-controlled studies of at least 4 weeks duration. Schmerz. 2015;29(1):47–59.
Budsberg SC, Torres BT, Kleine SA, Sandberg GS, Berjeski AK. Lack of effectiveness of tramadol hydrochloride for the treatment of pain and joint dysfunction in dogs with chronic osteoarthritis. J Am Vet Med Assoc. 2018;252(4):427–32.
Malek S, Sample SJ, Schwartz Z, Nemke B, Jacobson PB, Cozzi EM, et al. Effect of analgesic therapy on clinical outcome measures in a randomized controlled trial using client-owned dogs with hip osteoarthritis. BMC Vet Res BMC Veterinary Research. 2012;8(1):185.
KuKanich B. Outpatient Oral analgesics in dogs and cats beyond nonsteroidal Antiinflammatory drugs. An Evidence-based Approach. Vet Clin North Am - Small Anim Pract. 2013;43(5):1109–25.
Matthiesen T, Wöhrmann T, Coogan TP, Uragg H. The experimental toxicology of tramadol: an overview. Toxicol Lett. 1998;95:63–71.
Tørring ML, Riis A, Christensen S, Thomsen RW, Jepsen P, Søndergaard J, et al. Perforated peptic ulcer and short-term mortality among tramadol users. Br J Clin Pharmacol. 2008;65(4):565–72.
Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. J Clin Psychiatry. 2010;71(12):1565–75.
Case JB, Fick JL, Rooney MB. Proximal duodenal perforation in three dogs following deracoxib administration. J Am Anim Hosp Assoc. 2010;46(4):255–8.
Monteiro BP, Klinck MP, Moreau M, Guillot M, Steagall PV, Edge DK, et al. Analgesic efficacy of an oral transmucosal spray formulation of meloxicam alone or in combination with tramadol in cats with naturally occurring osteoarthritis. Vet Anaesth Analg. 2016;43(6):643–51.
Hill TL, Lascelles BDX, Law JM, Blikslager AT. The effect of tramadol and indomethacin coadministration on gastric barrier function in dogs. J Vet Intern Med. 2014;28(3):793–8.
Eskafian H, Shojaee Tabrizi A, Ansari Lari M. Gastroscopic study of meloxicam, tramadol, and their combined administration on the development of gastric injuries in dogs. Top Companion Anim Med. 2017;32(3):109–13.
Narita T, Sato R, Tomizawa N, Tani K, Komori S, Hara S. Safety of reduced-dosage ketoprofen for long-term oral administration in healthy dogs. Am J Vet Res. 2006;67(7):1115–20.
Pollmeier M, Toulemonde C, Fleishman C, Hanson PD. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis. Vet Rec. 2006;159(17):547–51.
Raekallio MR, Hielm-Björkman AK, Kejonen J, Salonen HM, Sankari SM. Evaluation of adverse effects of long-term orally administered carprofen in dogs. J Am Vet Med Assoc. 2006;228(6):876–80.
Lascelles BDX, McFarland JM, Swann H. Guidelines for safe and effective use of NSAIDs in dogs. Vet Ther. 2005;6(3):237–51.
Jergens AE, Turrentine MA, Kraus KH, Johnson GS. Buccal mucosa bleeding times of healthy dogs and of dogs in various pathologic states, including thrombocytopenia, uremia, and von Willebrand’s disease. Am J Vet Res. 1987;48(9):1337–42.
Blois SL, Allen DG, Wood RD, Conlon PD. Effects of aspirin, carprofen, deracoxib, and meloxicam on platelet function and systemic prostaglandin concentrations in healthy dogs. Am J Vet Res. 2010;71(3):349–58.
Forsyth SF, Guilford WG, Lawoko CR. Endoscopic evaluation of the gastroduodenal mucosa following non-steroidal anti-inflammatory drug administration in the dog. N Z Vet J. 1996;44(5):179–81.
Forsyth SF, Guilford WG, Haslett SJ, Godfrey J. Endoscopy of the gastroduodenal mucosa after carprofen, meloxicam and ketoprofen administration in dogs. J Small Anim Pract. 1998;39(9):421–4.
Flôr PB, Yazbek KV, Ida KK, Fantoni DT. Tramadol plus metamizole combined or not with anti-inflammatory drugs is clinically effective for moderate to severe chronic pain treatment in cancer patients. Vet Anaesth Analg. 2013;40(3):316–27.
Minami K, Ogata J, Horishita T, Shiraishi M, Okamoto T, Sata T, et al. Intramuscular tramadol increases gastric pH during anesthesia. Can J Anaesth. 2004;51(6):545–8.
Osinaike BB, Ogunro PS, Oyebamiji EO, Ogungbamigbe TO. Effects of varying doses of tramadol on gastric pH. Anesth Essays Res. 2013;7(1):25–8.
Ullah KM, Aqil M, Hussain A, Al Zahrani T, Hillis M. Effect of single oral dose of tramadol on gastric secretions pH. Saudi J Anaesth. 2015;9(1):9–11.
Lai Y, Ho Y, Huang K, Tsai LH. Effects of serotonin on acid secretion in isolated rat stomach: the role of 5-HT3 receptors. Chin J Physiol. 2009;52(5 Suppl):395–405.
Schlienger RG, Meier CR. Effect of selective serotonin reuptake inhibitors on platelet activation: can they prevent acute myocardial infarction? Am J Cardiovasc Drugs. 2003;3(3):149–62.
Monteiro BP, Klinck MP, Moreau M, Guillot M, Steagall PVM, Pelletier JP, et al. Analgesic efficacy of tramadol in cats with naturally occurring osteoarthritis. PLoS One. 2017;12(4):1–13.
Guedes AGP, Meadows JM, H PB, Johnson EG. Evaluation of tramadol for treatment of osteoarthritis in geriatric cats. J Am Vet Med Assoc. 2018;252:565–71.
Perez Jimenez TE, Mealey KL, Grubb TL, Greene SA, Court MH. Tramadol metabolism to O-Desmethyl tramadol (M1) and N-Desmethyl tramadol (M2) by dog liver Microsomes: species comparison and identification of responsible canine cytochrome P450s. Drug Metab Dispos. 2016;44(12):1963–72.
Pypendop BH, Ilkiw JE. Pharmacokinetics of tramadol, and its metabolite O -desmethyl-tramadol, in cats. J Vet Pharmacol Ther. 2008;31:52–9.
International association for the study of pain. Pain terms: a list with definitions and notes on usage. Recommended by the IASP Subcommittee on taxonomy. Pain. 1979;6(3):249.
D’Anjou M-A, Moreau M, Troncy E, Martel-Pelletier J, Abram F, Raynauld J-P, et al. Osteophytosis, subchondral bone sclerosis, joint effusion and soft tissue thickening in canine experimental stifle osteoarthritis: comparison between 1.5 T magnetic resonance imaging and computed radiography. Vet Surg. 2008;37(2):166–77.
Rialland P, Otis C, Moreau M, Pelletier J-P, Martel-Pelletier J, Beaudry F, et al. Association between sensitisation and pain-related behaviours in an experimental canine model of osteoarthritis. Pain. 2014;155(1):2071–9.
Keidel A, Mischke R. Clinical evaluation of platelet function analyzer PFA-100 in dogs. Berl Munch Tierarztl Wochenschr. 1998;111(11–12):452–6.
Goy-Thollot I, Chafotte C, Besse S, Garnier F, Barthez PY. Iohexol plasma clearance in healthy dogs and cats. Vet Radiol Ultrasound. 2006;47(2):168–73.
Rialland P, Bichot S, Moreau M, Guillot M, Lussier B, Gauvin D, et al. Clinical validity of outcome pain measures in naturally-occurring canine osteoarthritis. BMC Vet Res. 2012;8:162.